Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC)±bevacizumab – Results of the randomised GeparQuinto study (GBG 44)

✍ Scribed by Huober, Jens; Fasching, Peter A.; Hanusch, Claus; Rezai, Mahdi; Eidtmann, Holger; Kittel, Kornelia; Hilfrich, Jörn; Schwedler, Kathrin; Blohmer, Jens-Uwe; Tesch, Hans; Gerber, Bernd; Höß, Cornelia; Kümmel, Sherko; Mau, Christine; Jackisch, Christian; Khandan, Fariba; Costa, Serban Dan; Krabisch, Petra; Loibl, Sibylle; Nekljudova, Valentina; Untch, Michael; Minckwitz, Gunter von

• Book ID: 120409949
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 819 KB
• Volume: 49
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2013.02.027